POPULARITY
Categories
170 episodes with Obstetrics
123 episodes with Obstetrics
93 episodes with Obstetrics
78 episodes with Obstetrics
69 episodes with Obstetrics
66 episodes with Obstetrics
61 episodes with Obstetrics
62 episodes with Obstetrics
40 episodes with Obstetrics
94 episodes with Obstetrics
23 episodes with Obstetrics
32 episodes with Obstetrics
31 episodes with Obstetrics
16 episodes with Obstetrics
17 episodes with Obstetrics
12 episodes with Obstetrics
43 episodes with Obstetrics
38 episodes with Obstetrics
12 episodes with Obstetrics
19 episodes with Obstetrics
23 episodes with Obstetrics
18 episodes with Obstetrics
12 episodes with Obstetrics
31 episodes with Obstetrics
9 episodes with Obstetrics
8 episodes with Obstetrics
19 episodes with Obstetrics
22 episodes with Obstetrics
8 episodes with Obstetrics
9 episodes with Obstetrics
8 episodes with Obstetrics
6 episodes with Obstetrics
9 episodes with Obstetrics
8 episodes with Obstetrics
19 episodes with Obstetrics
9 episodes with Obstetrics
6 episodes with Obstetrics
6 episodes with Obstetrics
7 episodes with Obstetrics
6 episodes with Obstetrics
18 episodes with Obstetrics
9 episodes with Obstetrics
5 episodes with Obstetrics
8 episodes with Obstetrics
5 episodes with Obstetrics
12 episodes with Obstetrics
6 episodes with Obstetrics
7 episodes with Obstetrics
5 episodes with Obstetrics
7 episodes with Obstetrics
7 episodes with Obstetrics
8 episodes with Obstetrics
3 episodes with Obstetrics
7 episodes with Obstetrics
10 episodes with Obstetrics
5 episodes with Obstetrics
5 episodes with Obstetrics
6 episodes with Obstetrics
7 episodes with Obstetrics
4 episodes with Obstetrics
16 episodes with Obstetrics
5 episodes with Obstetrics
5 episodes with Obstetrics
6 episodes with Obstetrics
4 episodes with Obstetrics
3 episodes with Obstetrics
15 episodes with Obstetrics
3 episodes with Obstetrics
6 episodes with Obstetrics
12 episodes with Obstetrics
4 episodes with Obstetrics
6 episodes with Obstetrics
10 episodes with Obstetrics
4 episodes with Obstetrics
4 episodes with Obstetrics
4 episodes with Obstetrics
4 episodes with Obstetrics
2 episodes with Obstetrics
7 episodes with Obstetrics
8 episodes with Obstetrics
6 episodes with Obstetrics
15 episodes with Obstetrics
4 episodes with Obstetrics
4 episodes with Obstetrics
4 episodes with Obstetrics
5 episodes with Obstetrics
4 episodes with Obstetrics
4 episodes with Obstetrics
5 episodes with Obstetrics
2 episodes with Obstetrics
5 episodes with Obstetrics
5 episodes with Obstetrics
6 episodes with Obstetrics
2 episodes with Obstetrics
4 episodes with Obstetrics
4 episodes with Obstetrics
5 episodes with Obstetrics
3 episodes with Obstetrics
5 episodes with Obstetrics
3 episodes with Obstetrics
3 episodes with Obstetrics
3 episodes with Obstetrics
3 episodes with Obstetrics
8 episodes with Obstetrics
4 episodes with Obstetrics
4 episodes with Obstetrics
2 episodes with Obstetrics
4 episodes with Obstetrics
8 episodes with Obstetrics
3 episodes with Obstetrics
2 episodes with Obstetrics
3 episodes with Obstetrics
6 episodes with Obstetrics
6 episodes with Obstetrics
3 episodes with Obstetrics
5 episodes with Obstetrics
4 episodes with Obstetrics
Summary:In this episode of the Critical Care Obstetrics podcast, the hosts discuss the implications of a 'can-do' culture in healthcare, particularly in obstetrics. They explore how this attitude can lead to workarounds that, while initially well-intentioned, can negatively impact patient safety and staff well-being. The conversation delves into the importance of leadership in addressing these issues, the need for standardized assessments, and the dangers of normalizing deviations from best practices. The hosts emphasize the significance of clear roles during emergencies and the impact of burnout on healthcare professionals. They conclude with a call to action for team collaboration and empowerment to drive positive change in healthcare settings.The experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...
Exercise during pregnancy has long been encouraged, but clear guidance on what actually drives measurable physiological benefits has often been inconsistent. Episode 6 of The Research Debrief unpacks a newly published systematic review and meta-analysis from the American Journal of Obstetrics and Gynecology examining how structured exercise training during pregnancy impacts maternal biomarkers. The conversation moves beyond general outcomes and dives into what the latest science says about inflamation, metabolism, hormones and immune function — and what that means for fitness operators serving pregnant members. This Episode Explores: - A new systematic review and meta-analysis examining how exercise training during pregnancy impacts maternal biomarkers - Why combining aerobic and resistance training produces the strongest physiological benefits - How moderate to vigorous intensity exercise influences inflammatory, metabolic and hormonal markers - The importance of program duration — and why interventions longer than 12 weeks matter - Practical guidelines for structuring prenatal programs in health club settings This episode provides operators with evidence-based clarity on how to confidently program for pregnant members, highlighting that structured, longer-duration aerobic and strength training can positively influence key maternal health markers — creating opportunities for safe, strategic and science-backed prenatal offerings within clubs.
Kenny and Macca are joined live on air by Dr Hector Georgiou, Melbourne IVF, New laws on Surrogacy Hector holds a PhD from Imperial College London in Reproductive Endocrinology. He undertook postgraduate training in Obstetrics and Gynaecology at some of the most prestigious hospitals in Oxford and London, including highly competitive subspecialist training in Fertility and Reproductive Medicine. In addition, he completed a fellowship in Reproductive Endocrinology and IVF at the Royal Women's Hospital, Melbourne. Part of his enthusiasm for practicing medicine comes from seeing research translated into clinical practice. His research has been highly cited in respected medical journals and has been incorporated in professional society guidelines that influence global IVF practice. Hector holds a Clinical Senior Lectureship at the University of Melbourne, where his research focuses on luteal phase support and endometriosis. He is also leading a multidisciplinary team at the University of Oxford in the design and commercialization of a new egg collection needle, which has the capability to significantly boost egg numbers at IVF. His special interests include fertility treatment for LGBTQIA+ couples, egg freezing, onco-fertility, PCOS, recurrent implantation failure, ovulation induction, age-related infertility and unexplained fertility. Hector's patients appreciate his accessibility, compassion and evidence-based approach to care. Outside of work, Hector and his husband have recently adopted their beautiful Labrador Olive, and together they enjoy discovering new (doggie-friendly) brunch spots! http://@dr.hector.georgiou The post Sat, 14th, Feb, 2026: Dr Hector Georgiou, Melbourne IVF, New laws on Surrogacy appeared first on Saturday Magazine.
As BMIs and weights increase across the US population, there have been increased calls for universal screening for existing DM at entrance to prenatal care, if under 20 weeks. Others, including the ACOG, prefer to screen early those with additional risk factors (like prior GDM HX, prior macrosomia, BMI >30, PCOS, first degree relative with diabetes, or age >40). In July 2024, the ACOG released its publication, “Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum”. In this guidance, it states, “At this time, there are insufficient data to support the best screening modality for pregestational diabetes in pregnancy, but consideration can be made to use the same diagnostic criteria as for the nonpregnant population (A1c value 6.5 or higher, or fasting plasma glucose value 126 mg/dL or higher, or 2-hour plasma glucose value 200 mg/dL or higher during a 75-g OGTT, or random plasma glucose value 200 mg/dL or higher in patients with classic hyperglycemia symptoms)”. However, a new proposed protocol has been published in AJOG for early screening for DM in pregnancy. This also describes the differences in diagnosis and care for Standard GDM diagnosed at 24-28 weeks, vs a diagnosis of pregestational DM diagnosis made prior to 20-weeks vs “early” GDM also diagnosed under 20 weeks of gestation. Listen in for details. 1. McLaren, Rodney et al.nA Proposed Classification of Diabetes Mellitus in PregnancyAmerican Journal of Obstetrics & Gynecology, Volume 0, Issue 0. Epub Feb 2, 2026; https://www.ajog.org/article/S0002-9378(26)00061-X/fulltext2. ACOG Clinical Practice Update: Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum; July 2024; https://journals.lww.com/greenjournal/abstract/2024/07000/acog_clinical_practice_update__screening_for.34.aspx3. Simmons, David et al. “Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy.” The New England journal of medicine vol. 388,23 (2023): 2132-2144. doi:10.1056/NEJMoa2214956
Learn how ACOG turns advocacy into action, supports clinicians, and creates community. Plus, get tips on how you can get involved. In this episode of BackTable OBGYN, Dr. Sivani Aluru from Endeavor Health in Chicago shares her journey and involvement with ACOG, from her medical school days to her current role as the national JFCAC Chair. --- SYNPOSIS Dr. Aluru describes her experiences on various task forces, including the ACOG 75th Anniversary Task Force, and emphasizes the importance of education, advocacy, and community within the organization. She offers insights into the challenges and benefits of participating in ACOG, provides tips for getting involved, and highlights the ongoing efforts to address critical issues in women's health. The conversation also touches on adapting to the changes brought by the COVID-19 pandemic and the value of staying organized and connected in a demanding field. Find out what ACOG is working on, how it benefits patient care, how it benefits provider education and resources, how it builds community. Get involved! Go to meetings! There are so many roles. If you don't get your role on the first go, try again. Showing up is huge! --- TIMESTAMPS 00:00 - Introduction03:41 - Residency and Early Involvement in ACOG07:29 - Advocacy and Government Affairs18:40 - Balancing Professional and Organizational Work24:28 - Listening to Members' Needs26:36 - Challenges and Value of ACOG Membership29:00 - The Importance of In-Person Meetings34:45 - ACOG's Legislative Advocacy and Future Plans35:48 - Advice for Getting Involved with ACOG40:16 - Conclusion --- RESOURCES ACOG (American College of Obstetricians and Gynecologists)https://www.acog.org/ ACOG CAARE Delegation https://www.acog.org/about/diversity-equity-and-inclusive-excellence/collective-action-strategy/caare-delegation ACOG CREOG (Council on Resident Education in Obstetrics and Gynecology) https://www.acog.org/education-and-events/creog/about
In this episode of Rounding@IOWA, Dr. Gerry Clancy sits down with breast cancer experts Dr. Katherine Huber‑Keener and Dr. Nicole Fleege for a discussion of modifiable and non‑modifiable risk factors, modern screening tools, and practical strategies clinicians can use to guide prevention and early detection. CME Credit Available: https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=82146 Host: Gerard Clancy, MD Senior Associate Dean for External Affairs Professor of Psychiatry and Emergency Medicine University of Iowa Carver College of Medicine Guests: Nicole Fleege, MD Clinical Assistant Professor of Internal Medicine-Hematology, Oncology, and Blood and Marrow Transplantation University of Iowa Carver College of Medicine Kathryn Huber-Keener, MD PhD Clinical Associate Professor of Obstetrics and Gynecology - General Obstetrics and Gynecology University of Iowa Carver College of Medicine Financial Disclosures: Dr. Gerard Clancy, his guests, and Rounding@IOWA planning committee members have disclosed no relevant financial relationships. Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 0.75 ANCC contact hour. Pharmacist and Pharmacy Tech: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this knowledge-based activity for a maximum of 0.75 ACPE contact hours. Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must provide their NABP ID and DOB (MMDD) to receive credit. JA0000310-0000-26-035-H99 Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)
Guest: Lauren Osborne, M.D. Lauren Osborne, M.D., a reproductive psychiatrist at NewYork-Presbyterian and Weill Cornell Medicine and vice chair for clinical research for the Department of Obstetrics and Gynecology, discusses her research into the biological basis of postpartum depression. In a recent study, Dr. Osborne and her team were the first to analyze the entire metabolic pathway of progesterone, measuring both positive and negative allosteric modulators of the GABAA receptor throughout pregnancy and ultimately identifying a potential biomarker to predict risk. They are continuing to study and build upon these findings, with the goal of enabling better prediction and treatment options to address, or even prevent, postpartum depression. © 2026 NewYork-Presbyterian
In this episode, Dr. Margaret Larkins-Pettigrew, Professor and Academic Chair of Obstetrics and Gynecology at Drexel University School of Medicine, discusses closing gaps in maternal and child health, strengthening academic and healthcare partnerships, and addressing workforce shortages.
We unpack polyhydramnios with clear guidance on measurement, risk, and choices, showing why most mild cases near term are benign while outlining when to call in fetal medicine. Practical steps help parents and midwives stay calm, plan safely, and avoid unnecessary interventions.• definitions of polyhydramnios by single deepest pool and AFI• pros and cons of SDP versus AFI measurement• thresholds for mild, moderate, severe excess fluid• idiopathic cases late in pregnancy and prevalence• screening for gestational diabetes and infection• key risks: unstable lie, cord prolapse, postpartum haemorrhage• induction debates, continuous monitoring, and individualised plans• when to refer to fetal medicine and what they assess• amnioreduction indications, risks, and diagnostic value• reassurance for parents and guidance for midwivesIf you have, it'd be fantastic if you could subscribe, rate and review on whatever platform you find your podcasts, as well as recommending The OBSPod to anyone you think might find it interestingWant to know more:https://obgyn.onlinelibrary.wiley.com/doi/10.1111/tog.70021Thank you all for listening, My name is Florence Wilcock I am an NHS doctor working as an obstetrician, specialising in the care of both mother and baby during pregnancy and birth. If you have enjoyed my podcast please do continue to subscribe, rate, review and recommend my podcast on your podcast provider.If you have found my ideas helpful whilst expecting your baby or working in maternity care please spread the word & help theobspod reach other parents or staff who may be interested in exploring all things pregnancy and birth. Keeping my podcast running without ads or sponsorship is important to me. I want to keep it free and accessible to all but it costs me a small amount each month to maintain and keep the episodes live, if you wish to contribute anything to support theobspod please head over to my buy me a coffee page https://bmc.link/theobspodV any donation very gratefully received however small. Its easy to explore my back catalogue of episodes here https://padlet.com/WhoseShoes/TheObsPod I have a wide range of topics that may help you make decisions for yourself and your baby during pregnancy as well as some more reflective episodes on life as a doctor. If you want to get in touch to suggest topics, I love to hear your thoughts and ideas. You can find out more about me on Twitter @FWmaternity & @TheObsPod as well as Instagram @TheObsPod and e...
Our first VBAM (vaginal birth after myomectomy) was Episode 189 with Mabel back in 2022 and we are SO excited to finally be bringing you another! Maria Magdalena “Mags” Campbell joins us from Cape Town, South Africa to share her inspiring story through loss, fertility challenges, and ultimately TWO VBAM births. With the support of Chinese medicine, acupuncture, progesterone, and a fertility coach, Mags went on to conceive her son naturally. She met with 8 doctors before finally finding a VBAM supportive provider and hospital at 32 weeks. After a successful ECV for a breech baby, she went on to have a hospital VBAM with an epidural at 9 cm at 40+1 weeks, welcoming her 3.9-kg son.Her second pregnancy came easily and felt very different. Mags prepped similarly with things like Chinese medicine and acupuncture, but leaned even more into holistic prep through breathwork, meditation, yoga, and doula support. Mags chose a hospital birth over a home birth and went on to have a euphoric, unmedicated vaginal water birth at 40+3 weeks, welcoming her 4.1-kg daughter.During her prep, Mags connected with Mabel and she hopes that her stories can bring the same inspiration that Mabel's did for her. We are also posting a new blog all about VBAM in honor of Mags' episode that you can find at www.thevbaclink.com/blog. American Journal of Obstetrics & Gynecology (AOGS)PubMed StudyEuropean Journal of Obstetrics & GynecologyJournal of Obstetrics and Gynaecology Canada (JOGCScienceDirect ReviewEpisode 189 Mabel's VBAM (Vaginal Birth After Myomectomy)Support this podcast at — https://redcircle.com/the-vbac-link/donationsAdvertising Inquiries: https://redcircle.com/brands
Pam Simon, MSN, CPNP, CPON, Stanford Adolescent and Young Adult Cancer Program (SAYAC), Palo Alto, CA and H. Irene Su, MD MSCE, University of California San Diego, San Diego, CA Recorded on January 20, 2026 Pam Simon, MSN, CPNP, CPON Nurse Practitioner & Program Manager Stanford Adolescent and Young Adult Cancer Program (SAYAC) Palo Alto, CA H. Irene Su, MD MSCE Professor Reproductive Endocrinology and Infertility Fellowship Director Division of Reproductive Endocrinology and Infertility Co-Director, Center for Obstetrics and Gynecology Research Innovations Department of Obstetrics, Gynecology and Reproductive Sciences Director, Moores Cancer Center Leadership Academy University of California San Diego San Diego, CA In this episode, we're joined by Dr. Irene Su, Professor of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego, and Pam Simon, Nurse Practitioner and Program Manager of the Stanford Adolescent and Young Adult (AYA) Cancer Program at Stanford Medicine. They discuss fertility risk across treatment types, approaches to fertility preservation and reproductive survivorship planning, insurance and access considerations, and the cultural and sociodemographic factors that shape care. They also share strategies to support shared decision-making and promote psychosocial well being for AYA patients and survivors. Tune in for practical insights to strengthen your approach to fertility care for AYAs. Mentioned on this episode: OncofertilityRisk.com The Alliance for Fertility Preservation Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients
In this episode of the Critical Care Obstetrics podcast, Dr. Stephanie Martin and her colleagues discuss the concept of 'Can-Do Culture' in healthcare, particularly in obstetrics. They explore personal stories that illustrate the challenges and consequences of this mindset, especially regarding patient safety and staffing issues. The conversation emphasizes the importance of understanding the scope of service, the impact of a can-do attitude on patient outcomes, and the need for structured processes in healthcare settings. They also highlight the role of simulation as a tool for improving efficiency and problem-solving in clinical practice. The episode concludes with a call for further discussion on the implications of can-do culture on individual healthcare providers and the potential for burnout.The experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...
Join me and my guest Jamie Knopman, MD, a board certified reproductive endocrinologist and Director of Fertility Preservation for CCRM Fertility of New York. She is also Assistant Clinical Professor in Obstetrics and Gynecology at Mount Sinai Hospital. We explore the intersection of fertility, career-building, and personal agency and why equitable access to egg freezing is essential to gender equality in the workplace and beyond. Jamie brings not only deep clinical expertise, but also a culturally sharp, unapologetically feminist perspective on why women shouldn't have to choose between thriving professionally and preserving their future ability to have children. Nearly 70% of her patients today are freezing eggs before they face infertility. And companies such as Meta, Disney, and Amazon often cover the cost. She also highlights new pathways like egg-sharing programs that allow women to preserve their fertility at no cost, if they choose to donate a portion of their eggs. These trends reflect a cultural shift, and one she believes we urgently need to accelerate. SHOW NOTES SPONSORED BY: Power of You! https://leader.blainebartlett.com/power-of-you Summary In this conversation, Blaine and Dr. Jamie Knopman discusses the evolving landscape of fertility, particularly focusing on egg freezing and embryo preservation. She highlights the importance of education and empowerment for women in making informed choices about their reproductive health. The discussion also touches on the emotional dynamics surrounding fertility, the role of companies in supporting women's choices, and future innovations in fertility medicine. Dr. Knopman emphasizes the need for a supportive work environment that recognizes the unique challenges women face in balancing career and family planning. Takeaways The shift from infertility to fertility preservation is significant. Egg freezing allows women to maintain reproductive autonomy. Companies are increasingly offering fertility benefits to attract talent. Emotional dynamics play a crucial role in fertility decisions. Work-life balance requires planning and support systems. Education about fertility is essential for informed choices. Women are empowered to take charge of their reproductive health. Future innovations in fertility medicine are promising. The journey of life is fluid and not linear. Supportive work environments enhance women's contributions. Learn more about your ad choices. Visit megaphone.fm/adchoices
We have learned a lot about extended spectrum coverage of prophylactic antibiotics for cesarean section. The landmark C/SOAP trial randomized 2,013 women undergoing nonelective cesarean delivery to azithromycin 500 mg IV plus standard prophylaxis versus placebo, demonstrating a 51% reduction in the composite outcome of endometritis, wound infection, or other infection. Adjuvant Zmax (plus standard first-generation cephalosporin) is now recognized as evidence-based antibiotic coverage for intrapartum cesarean, cesarean with ruptured membranes, and patients with obesity. This last patient characteristic comes from the ERAS latest update. But what is ZMAX is not available? Is there an evidence-based peri-op alternative in these cases? Does Gent and Clinda cover mycoplasma/Ureaplasma? What about postop flagyl? Listen in for details. 1. Tita AT, Szychowski JM, Boggess K, et al. Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. The New England Journal of Medicine. 2016. 2. Yang M, Yuan F, Guo Y, Wang S. Efficacy of Adding Azithromycin to Antibiotic Prophylaxis in Caesarean Delivery: A Meta-Analysis and Systematic Review. International Journal of Antimicrobial Agents. 2022. 2. ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. Obstetrics and Gynecology. 2018. Committee on Practice Bulletins-Obstetrics 3. Martingano D, Nguyen A, Nkeih C, Singh S, Mitrofanova A. Clarithromycin Use for Adjunct Surgical Prophylaxis Before Non-Elective Cesarean Deliveries to Adapt to Azithromycin Shortages in COVID-19 Pandemic. PloS One. 2020. 4. Valent AM, DeArmond C, Houston JM, et al. Effect of Post–Cesarean Delivery Oral Cephalexin and Metronidazole on Surgical Site Infection Among Obese Women: A Randomized Clinical Trial. The Journal of the American Medical Association. 2017. 5. Wood, G. E., et al. "In Vitro Susceptibility of Mycoplasma genitalium to Nitroimidazoles." Antimicrobial Agents and Chemotherapy 6. https://www.cdc.gov/std/treatment-guidelines/mycoplasmagenitalium.htm
Dr. Peter Antevy returns to the Inside EMS co-host seat this week, filling in for Kelly Grayson and bringing some serious pediatric firepower to the conversation. Host Chris Cebollero dives right into the latest buzz around the Broselow tape recall — yes, again — as Dr. Antevy unpacks what went wrong, why it matters and what EMS agencies should be doing about it now. He also shares exciting details on his brand-new, field-focused Newborn Resuscitation & Obstetrics course (NROC), built by EMS for EMS. Designed with two hours of online content (zero PowerPoints!) and a short, in-house skills lab, this course aims to tackle one of the most nerve-wracking call types. No more dragging medics to the hospital for NRP classes that don't translate to street-level care. Also on deck: OB deserts, delayed cord clamping, why you might need to Saran-wrap a newborn (seriously), and what AI can — and can't — do for EMS. This one's packed with practical pearls, myth-busting insights and a whole lot of passion for pediatric education. Quotable takeaways from Dr. Peter Antevy “EMS is one specialty that AI will never take away, as far as like the human-to-human contact. We resuscitate people, we treat people who are seizing. AI will never do that. That's a good thing.” “Academics and the hospital folks don't recognize the value that EMS brings to the table. They think we're ambulance drivers. It's time for them to wake up and recognize that we are the people who deliver babies. We are the people who resuscitate grandma, grandpa and the little kid.” Enjoying Inside EMS? Email theshow@ems1.com to share feedback or suggest guests for future episodes.
Dr. Rupsa Boelig, a 2025 March of Dimes Discovery Research Grant winner and an Associate Professor of Obstetrics and Gynecology in the Division of Maternal Fetal Medicine at Philadelphia's Thomas Jefferson University, discusses her new study on the metabolism of aspirin in pregnant women with diabetes or a higher BMI. She hopes the study findings will shed light on whether these women may benefit from a higher aspirin dose to help prevent preeclampsia and/or preterm birth.
As OB healthcare providers, we have several pieces of guidance regarding determination of amniotic fluid volume antepartum. The SMFM has Consult Series #46 (2018), which describes the management of polyhydramnios. We'll touch on that in this episode. However, while we have clear understanding of the increased risks of oligohydramnios, where an MVP is preferred for diagnosis over AFI, we have less information about polyhydramnios. But a new study published in BJOG (January 2026) provides more insights on this. While MVP is preferred for oligo diagnosis, can the same be said for polyhydramnios? Is there an increased risk in perinatal morbidity with polyhydramnios, and is that better detected by MVP or AFI? This new study findings left the authors unsatisfied although it CONFIRMED what we have covered in past episodes. Listen in for details.1. Dashe, Jodi S. et al. SMFM Consult Series #46: Evaluation and management of polyhydramnios. American Journal of Obstetrics & Gynecology, Volume 219, Issue 4, B2 - B8 (2018)2. ACOG PB 229: Antepartum Fetal Surveillance (2021)3. Petrecca A, Chauhan SP, Tersigni C, Ghi T, Berghella V. Amniotic Fluid Index Versus Maximum Vertical Pocket Versus Both for Polyhydramnios. BJOG. 2026 Jan 7. doi: 10.1111/1471-0528.70139. Epub ahead of print. PMID: 41502220.
Back in March of 2025, the green journal (obstetrics andgynecology) published A systematic review and meta-analysis on 2 medications (non-hormonal) and their efficacy in menopausal hot flash relief period these medications were Fezolinetant and Elinzanetant. However, the editors have just recently released an “Expression of Concern” about this review. Listen in for details. 1. Menegaz de Almeida, Artur MS; Oliveira, PalomaMS; Lopes, Lucca MD; Leite, Marianna MS; Morbach, Victória MS; Alves Kelly,Francinny MD; Barros, Ítalo MS; Aquino de Moraes, Francisco Cezar MS;Prevedello, Alexandra MD. Fezolinetant and Elinzanetant Therapy for MenopausalWomen Experiencing Vasomotor Symptoms: A Systematic Review and Meta-analysis.Obstetrics & Gynecology 145(3):p 253-261, March 2025. | DOI:10.1097/AOG.00000000000058122. Expression of Concern: Fezolinetant andElinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: ASystematic Review and Meta-Analysis. Obstetrics & Gynecology():10.1097/AOG.0000000000006180, January 16, 2026. | DOI: 10.1097/AOG.0000000000006180
Implanon (etonogestrel implant) first received FDA approval in 2006, followed by the improved, radiopaque version, Nexplanon, approved by the FDA in 2010, which is now the only contraceptive implant available in the U.S. It was originally FDA approved for a 3-year use duration, although peer reviewed clinical data had demonstrated efficacy through year 5. Now, as of January 2026, the FDA has formally agreed to extend the label for 5-year use. In this episode, we will review the clinical data that prompted the FDA's decision, based on a multicenter, single-arm, open-label study evaluating contraceptive efficacy and safety during years 4 and 5 of implant use.1. https://www.contemporaryobgyn.net/view/fda-approves-5-year-use-for-etonogestrel-implant-68-mg-contraceptive2. Organon announces US Food and Drug Administration approval of supplemental new drug application extending duration of use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque. Organon. Press release. January 16, 2026. Accessed January 19, 2026. https://www.organon.com/news/organon-announces-us-food-and-drug-administration-approval-of-supplemental-new-drug-application-extending-duration-of-use-of-nexplanon-etonogestrel-implant-68-mg-radiopaque/3. Ali M, Akin A, Bahamondes L, et al. Extended Use Up to 5 Years of the Etonogestrel-Releasing Subdermal Contraceptive Implant: Comparison to Levonorgestrel-Releasing Subdermal Implant. Human Reproduction. 2016. 4. McNicholas C, Swor E, Wan L, Peipert JF. Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device: 2 Years Beyond Food and Drug Administration-Approved Duration. American Journal of Obstetrics and Gynecology. 2017. 5. McNicholas C, Maddipati R, Zhao Q, Swor E, Peipert JF. Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device Beyond the U.S. Food and Drug Administration-Approved Duration. Obstetrics and Gynecology. 2015.
What if maternal health goals expanded beyond "alive and healthy"? In honor of Maternal Health Awareness Day, Debra Pascali-Bonaro invites us to imagine a world where pregnancy, birth, and postpartum care are not only safe but also deeply respectful, emotionally whole, and infused with comfort and pleasure. In this moving solo episode, Debra shares her personal connection to the origins of Maternal Health Awareness Day—beginning in her home state of New Jersey—and explores how far the movement has come, and how far we still must go. With maternal mortality rates rising across the U.S. and nearly 80% of pregnancy-related deaths proven preventable, Debra calls us to collective action: to hold ground, raise our voices, and reclaim maternal health as a human right. From advocacy and policy to embodied care and global collaboration, this episode invites you to consider: what does it mean to move from surviving to thriving with safety, love, and pleasure? In this episode, you'll learn: The origins of Maternal Health Awareness Day and its urgent mission. Why systemic inequities—not personal failures—drive maternal mortality rates. How safety, equity, and pleasure are biologically connected in birth. The protective power of respect, love, and support during birth and postpartum. Practical advocacy steps for expectant parents, birth workers, and allies. Mentioned in this episode: International MotherBaby Childbirth Organization @internationalmotherbabychi3946 International Childbirth Initiative (ICI) @internationalchildbirthini2273 FIGO (International Federation of Gynecology and Obstetrics) ICM (International Confederation of Midwives) @WorldMidwives American College of Obstetricians and Gynecologists (ACOG) Eat Pray Doula Advanced Retreats www.eatpraydoula.com Pleasurable Birth Essentials https://www.orgasmicbirth.com/pleasurable-birth-essentials Resources & Next Steps: Learn more and access free resources at https://www.orgasmicbirth.com/black-maternal-health-birth-equity-resources Share how you're holding ground on maternal health using #OrgasmicBirth and tag @orgasmicbirth on social media. Review and follow the show—we'd love to hear how this episode inspired you! Connect with Debra! Website: https://www.orgasmicbirth.com Instagram: / orgasmicbirth X: / orgasmicbirth YouTube / orgasmicbirth1 Tik Tok / orgasmicbirth LinkedIn: / debra-pascali-bonaro-1093471 ----
Ursodiol (ursodeoxycholic acid) is a prescription bile acid medication used to dissolve cholesterol gallstones, prevent gallstones during rapid weight loss, and treat liver diseases like primary biliary cholangitis (PBC) by reducing toxic bile acids and cholesterol production. It works by changing bile composition, making it less saturated with cholesterol, and is available as oral medication. Of course, it is also the foundational medication for treatment of diagnosed Intrahepatic Cholestasis of Pregnancy (ICP). Does this medication reduce adverse perinatal outcomes? In this episode, we will review a new study from the Green Journal, which will be out in February 2026, examining the recurrence risk for ICP using data from NY. In a patient with prior history of ICP, is there any guidance on monitoring of serum bile acids in the subsequent pregnancy before symptoms develop? We will explain. PLUS we will review the data on whether Ursodiol may hold promise in recurrence prevention or in reduction of adverse outcomes once the condition is diagnosed. Listen in for details. 1. 2019: Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG; PITCHES study group. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet. 2019 Sep 7;394(10201):849-860. doi: 10.1016/S0140-6736(19)31270-X. Epub 2019 Aug 1. PMID: 31378395; PMCID: PMC6739598. https://pubmed.ncbi.nlm.nih.gov/31378395/2. February 08, 2025: Rahim, Mussarat N et al. Pregnancy and the liver. The Lancet. 2021; Volume 405, Issue 10477, 498 – 513 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02351-1/fulltext3. SMFM CS 53; 20214. Rosenberg, Henri M. MD; Sarker, Minhazur R. MD; Ramos, Gladys A. MD; Bianco, Angela MD; Ferrara, Lauren MD; DeBolt, Chelsea A. MD. Intrahepatic Cholestasis of Pregnancy Recurrence in a Subsequent Pregnancy. Obstetrics & Gynecology 147(2):p 239-241, February 2026. | DOI: 10.1097/AOG.0000000000006033 https://journals.lww.com/greenjournal/fulltext/2026/02000/intrahepatic_cholestasis_of_pregnancy_recurrence.13.aspx5. Ovadia C, Sajous J, Seed PT et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):547-558. doi: 10.1016/S2468-1253(21)00074-1. Epub 2021 Apr 27. PMID: 33915090; PMCID: PMC8192305.6. EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy. European Association for the Study of the Liver; 2023
Feeling exhausted, foggy, short of breath, or just not like yourself during pregnancy and being told “that's normal”? This episode is for you. In Episode 417 of The Birth Lounge, HeHe sits down with OB/GYN PA and public health expert Kristy Goodman to talk about anemia in pregnancy and why it's so often overlooked, minimized, or brushed off until it becomes a much bigger issue. Together, they break down what anemia actually is, how and when it should be screened for, and why catching it early can completely change how you feel during pregnancy, labor, and postpartum. They explore how untreated anemia can impact energy levels, labor stamina, recovery, and overall well-being, and more importantly, what becomes possible when it's properly identified and treated with intention. Think more clarity, more strength, better healing, and the confidence to advocate for yourself instead of second-guessing your symptoms. Kristy brings an evidence-based, patient-centered lens to this conversation, helping listeners understand what labs matter, what questions to ask their provider, and how to push back when concerns are dismissed as “just part of pregnancy.” This episode is grounding, empowering, and deeply validating. If you've ever felt brushed off, unsure whether what you're feeling is normal, or just want to feel stronger and more supported in your body, this conversation will give you real tools and real answers.
Tara Eicher is a postdoctoral research fellow in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Eicher, J. Quackenbush, and A. Ne'eman. Challenging Claims of an Autism Epidemic — Misconceptions and a Path Forward. N Engl J Med 2026;394:313-315.
Safer Care Victoria, a State Government agency, has recently released a set of guidelines for clinicians to help them navigate situations where a woman rejects their medical advice. The guide is titled the Respectful Maternity and Newborn Care Framework and is described as "a practical tool that supports clinicians and consumers genuine partnership — especially when a woman makes an informed decision about her care pathway that differs from clinical recommendations." In this edition of the Conversation Hour we speak with the Royal Australian and New Zealand College of Obstetrics and Gynaecologists to get a better understanding of the guidelines and why they have been introduced.Also in this edition — from births to deaths, we talk whether there needs to be greater regulation around funeral directors. Plus, what are crisps doing on the tables of fancy restaurants? And we bring you all the latest from The Australian Open.
The conversation also addresses the moral distress clinicians experience when a mother dies.This episode is for anyone who cares for pregnant or postpartum patients and wants to be better prepared—not just clinically, but emotionally and ethically—when the unthinkable happens. It is a reminder that even when we cannot save a life, how we care still matters profoundly.#MaternalMortality #MaternalHealth #MaternalDeath #PreventableDeaths #MaternalSafety #Postpartum #HighRiskPregnancy #MaternalHealthCrisis #HealthEquity #PerinatalCare #OBGYNThe experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...
Behind the Knife ABSITE 2026 – Up-to-date and high yield learning to help you DOMINATE the exam.Don't forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheetBe sure to check out our free study aid, which includes all 32 review episodes, brief written summaries, high yield images, and flash cards. Simply create an account on our iOS or Android app or on our website and you will find the entire course in your Library. Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Google Play App Store: https://play.google.com/store/apps/details?id=com.btk.appBehind the Knife would like to sincerely thank Medtronic for sponsoring the entire 2026 ABSITE podcast series. Medtronic has a rich history of supporting surgical education, and we couldn't be happier that they chose to partner with Behind the Knife. Learn more at https://www.medtronic.com/en-us/index.htmlIf you like the work that Behind the Knife is doing, please leave us a review wherever you listen to podcasts. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. Check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewBehind the Knife in Español - repaso para el examen de certificación en cirugía general: https://app.behindtheknife.org/premium/repaso-para-el-examen-de-certificaci-n-en-cirug-a-general
The ENG implant has data placing it as the most reversible, hormonal contraceptive agent available with a typical use failure rate of 0.05%. Unfavorable bleeding patterns, such as frequent or prolonged bleeding, affect approximately 40% of ENG implant users within the first 3 months but typically improve over time. Nonetheless, it is the main reason for patient discontinuation. In the past, various medications have shown to have at least some short-term reduction in bothersome breakthrough bleeding (BTB). These include doxycycline, ethinyl estradiol (EE), mefenamic acid, combined oral contraceptives (COCs), short term tamoxifen, norethindrone, and ulipristal acetate. In this episode, we will summarize a new RCT (AJOG, released as epub on Jan 7, 2026) which describes the use of TXA for ENG related BTB. Did it work? Listen in for details.1. Andrade, Maíra Cristina Ribeiro et al. Norethisterone for prolonged uterine bleeding associated with etonogestrel implant (IMPLANET): a randomized controlled trialAmerican Journal of Obstetrics & Gynecology, Volume 234, Issue 1, 101 - 1152. Edelman, Alison et al. Treatment of unfavorable bleeding patterns in contraceptive implant users with tranexamic acid: randomized clinical trial. American Journal of Obstetrics & Gynecology, Volume 0, Issue (Articles in Press January 07, 2026)
In vitro fertilization, or IVF, can cost upwards of $20,000 in California — for one cycle. For that reason, it's put financial strain on many California families and been completely out of reach for others, including couples who have faced insurance denials because they are LGBTQ+. But a California law that went into effect this month, SB 729, requires large employer-sponsored health plans to cover up to three cycles of IVF, along with other infertility services, regardless of sexual orientation. We'll hear what the new law means for family planning in California, and for you: Does this put IVF within reach for you? What's been your experience with IVF? Guests: Caroline Menjivar, member of the California State Senate representing the 20th district (San Fernando Valley) Shefali Luthra, reproductive health reporter, The 19th Sarah Jolly, has been trying to conceive with her husband for five years Dr. Alexander Quaas, medical director Shady Grove Fertility San Diego; fertility specialist; wrote an article for the American Journal of Obstetrics & Gynecology titled, “The California infertility insurance mandate: another step toward reproductive justice?” Learn more about your ad choices. Visit megaphone.fm/adchoices
If you go by pop culture depictions, menopause seems like no big deal — a few hot flashes, some comical bouts of hormone-fueled rage, and the “big change,” as it was once called, is over. But for many of the 2 million American women who enter menopause each year, the symptoms can be a lot more serious and long-lasting, ranging from vertigo and joint pain to brain fog and heart problems.On this episode, we take a deep dive into perimenopause and menopause – what's going on biologically? What can be done to ease symptoms? And why do so many women struggle to receive help from their doctors?We talk with menopause experts about hormone replacement therapy, and why it was demonized for many years; find out what researchers have discovered about the causes of brain fog; and hear about new efforts to deal with medically induced menopause. In this excerpt from our live event, Reimagining Menopause, host Maiken Scott talks with two certified menopause providers — Robyn Faye, an OB-GYN at Jefferson Health in Philadelphia, and Arina Chesnokova, assistant professor in of Obstetrics and Gynecology at the University of Pennsylvania's Perelman School of Medicine — about the ins and outs of hormone therapy, which symptoms it alleviates, when it's safe and when it's not. Watch the full discussion here. Reporter Alan Yu talks with researchers about what's behind one of the most vexing symptoms of menopause for many women — brain fog. For women who have cancer when they're younger, especially breast or ovarian cancer, chemotherapy and other medications needed to treat the disease can affect hormones - and suddenly plunge them into menopause, years before they might naturally experience it. We explore what their options are, and why so many say they were not prepared for this change.
A Podcast from Obstetrics & Gynecology highlighting the latest research and practice updates in the field. This episode features interviews with Drs. Amrin Khander and Line Malha, authors of "Comparison of 162 mg and 81 mg Aspirin for Prevention of Preeclampsia: A Randomized Controlled Trial," and Erin Chang and Dr. Emily S. Miller, authors of "Smartphone Applications to Support Perinatal Mental Health."
It's a controversial topic: the impact of uterine incision (hysterectomy) on the neonate delivery interval (also called the U-D interval). Does it matter? Just to be clear, we're talking about time from uterine entry to fetal extraction, not skin incision to fetal extraction. Past publications have produced conflicting results, often limited by small sample sizes, heterogeneous indications for delivery, and reliance on surrogate markers (like apgar scores) rather than clinical morbidity. But a new study published in the Gray journal at the end of 2025 (December 30, 2025) gives some new insights. In this episode, we will review this retrospective study and play the “Devil's advocate” as we summarize the rebuttal data. As the reports are conflicting, we will end the podcast with a real-world interpretation and application of this data. Listen in for details. 1. Bart, Yossi et al. Uterine Incision-to-Delivery Interval and Neonatal Outcomes among Non-urgent, Term, Cesarean Deliveries. American Journal of Obstetrics & Gynecology, Volume 0, Issue 0. https://www.ajog.org/article/S0002-9378(25)00980-9/fulltext?rss=yes2. Maayan-Metzger A, Schushan-Eisen I, Todris L, Etchin A, Kuint J. The effect of time intervals on neonatal outcome in elective cesarean delivery at term under regional anesthesia. Int J Gynaecol Obstet. 2010 Dec;111(3):224-8. doi: 10.1016/j.ijgo.2010.07.022. Epub 2010 Sep 19. PMID: 20855070. https://pubmed.ncbi.nlm.nih.gov/20855070/3. Spain JE, Tuuli M, Stout MJ, Roehl KA, Odibo AO, Macones GA, Cahill AG. Time from uterine incision to delivery and hypoxic neonatal outcomes. Am J Perinatol. 2015 Apr;32(5):497-502. doi: 10.1055/s-0034-1396696. Epub 2014 Dec 24. PMID: 25539409.4. Bader AM, Datta S, Arthur GR, Benvenuti E, Courtney M, Hauch M. Maternal and fetal catecholamines and uterine incision-to-delivery interval during elective cesarean. Obstet Gynecol. 1990 Apr;75(4):600-3. PMID: 2107478.5. Tekin, E., Inal, H.A. & Isenlik, B.S. A Comparison of the Effect of Time from Uterine Incision to Delivery on Neonatal Outcomes in Women with One Previous and Repeat (Two or More) Cesarean Sections. SN Compr. Clin. Med. 5, 80 (2023). https://doi.org/10.1007/s42399-023-01427-x
In this conversation, Dr. Tomer Singer shares his personal journey into reproductive medicine, influenced by his family's struggles with infertility. He discusses the unique challenges faced by Orthodox couples in fertility treatments and the importance of community engagement. The conversation also covers the rise of egg freezing as a viable option for women, the optimal age for freezing eggs, and the success rates of frozen eggs. Dr. Singer emphasizes the role of nutrition and AI in improving patient care and outcomes in reproductive medicine. He concludes with thoughts on the future of fertility treatments.Chapters00:00 The Journey into Fertility Medicine02:50 Understanding Orthodox Fertility Practices05:39 Navigating Religious and Medical Collaboration08:54 Education and Communication in Fertility11:40 The Rise of Egg Freezing15:01 Optimal Age for Egg Freezing17:58 Success Rates of Frozen Eggs20:39 Improving Egg Quality and Patient Health23:59 Future of Egg Freezing Technology29:51 Understanding the Costs of Egg Freezing32:59 The Importance of Egg Freezing for Future Fertility34:08 The Age Visit: A New Approach to Women's Health38:18 The Role of AI in Reproductive Medicine41:25 Job Security in the Age of AI45:23 Future Trends in Fertility Treatments48:46 Rapid Fire Questions on Fertility Practices52:28 Prioritizing Mental Health in a Busy Life54:25 Connecting with Dr. SingerAbout Dr. Tomer Singer:Tomer Singer, MD, MBA is an internationally renowned Endocrinologist and Infertility Specialist. He serves as the System Chief of Reproductive Endocrinology and Infertility at Northwell Health where he is responsible for programmatic strategy and fosters academic and clinical growth. Dr. Singer earned his medical degree from the Sackler School of Medicine and an MBA in Health Care Management from the Hofstra Zarb School of Business. He is double board- certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. He is an Associate Professor of OB/GYN at the Donald and Barbara Zucker School of Medicine. Dr. Singer has produced numerous publications, chapter reviews, and given presentations nationally and internationally in the field of Infertility, Reproductive Endocrinology, IVF, Pre-Implantation Genetic Testing (PGT), Egg Freezing, Egg Donation, and Gestational Surrogacy. He has performed hundreds of minimally invasive surgical procedures including laparoscopies and hysteroscopies. Dr. Singer has held several senior roles at Lenox Hill Hospital where he served as the Director of Reproductive Endocrinology and Infertility, the Vice Chairman of the Department of OB/GYN, Director of Egg Freezing, and the OB/GYN Residency Program Director. Dr. Singer's commitment to helping thousands of patients has earned him several awards including the Castle Conolly Top Doctor Award every year since 2017. Contact Dr. Tomer SingerInstagram @tsingermd
Doctors have long recommended regular cervical cancer screenings. Traditionally doctors perform these exams using a speculum, which often say is uncomfortable and, for many, quite painful. Some recent developments could make a large number of these screenings easier. In early January, the Health Resources and Services Administration, which is part of the Department of Health and Human Services, updated its guidelines to say that self-administered tests are an acceptable way to screen for human papillomavirus. HPV is a sexually-transmitted disease that causes the majority of cervical cancer cases. OB-GYNs are hopeful that at-home testing will make cervical cancer screenings easier to access…. and significantly more comfortable. Guests: Dr. Linda Eckert, professor of Obstetrics and Gynecology at the University of Washington School of Medicine Related links: New Guidelines Endorse Self-Swab Alternative to Pap Smear for Cervical Cancer Testing - The New York Times Cervical Cancer Risk Factors | Cervical Cancer | CDC The FDA has approved an at-home HPV test. What you need to know : NPR Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.
Better Edge : A Northwestern Medicine podcast for physicians
In this episode of Parts and Labor, Angela Chaudhari, MD, hosts a panel of experts from Northwestern Medicine's Division of Gynecologic Oncology to discuss the groundbreaking research and clinical trials shaping the future of gynecologic cancer care. The panel explores innovations in immunotherapy, investigator-initiated trials, survivorship and symptom science, while highlighting efforts to expand access and diversity in clinical research across Chicago and the surrounding suburbs.This episode's panel of guests includes:• Emma L. Barber, MD, John and Ruth Brewer Professor of Gynecology and Cancer Research, Division Chief of Gynecologic Oncology and Director of Robotic Surgery• Daniela E. Matei, MD, Diana, Princess of Wales Professor of Cancer Research and Chief of Reproductive Science in the Departments of Obstetrics and Gynecology and Hematology and Oncology• Dario R. Roque, MD, Associate Professor of Gynecologic Oncology and Fellowship Program Director• Emily M. Hinchcliff, MD, Assistant Professor of Gynecologic Oncology and Program Director of the OB-GYN Residency Program
Join Dr. Clancy and his guests, Drs. Evelyn Ross-Shapiro, Sarah Shaffer, and Emily Walsh, as they discuss the complex set of symptoms and treatment options for those with significant symptoms from menopause. CME Credit Available: https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=81895 Host: Gerard Clancy, MD Senior Associate Dean for External Affairs Professor of Psychiatry and Emergency Medicine University of Iowa Carver College of Medicine Guests: Evelyn Ross-Shapiro, MD, MPH Clinical Assistant Professor of Internal Medicine Clinic Director, LGBTQ Clinic University of Iowa Carver College of Medicine Sarah Shaffer, DO Clinical Associate Professor of Obstetrics and Gynecology Vice Chair for Education, Department of Obstetrics and Gynecology University of Iowa Carver College of Medicine Emily Walsh, PharmD, BCACP Clinical Pharmacy Specialist Iowa Health Care Financial Disclosures: Dr. Gerard Clancy, his guests, and Rounding@IOWA planning committee members have disclosed no relevant financial relationships. Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 1.00 ANCC contact hour. Pharmacist and Pharmacy Tech: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this knowledge-based activity for a maximum of 1.00 ACPE contact hours. Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must provide their NABP ID and DOB (MMDD) to receive credit. JA0000310-0000-26-029-H01 Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.) References/Resources:
An easy way to learn APGAR, a scoring system designed to assess newborns. Includes APGAR mnemonic! PDFs available here: https://rhesusmedicine.com/pages/paediatricsConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Buy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is the APGAR Score?0:19 APGAR Score Mnemonic1:50 APGAR Score Interpretation / APGAR Score MeaningMSD Manual Professional Edition (2025) Neonatal resuscitation. MSD Manual Professional Edition. Available at: https://www.msdmanuals.com/professional/pediatrics/perinatal-problems/neonatal-resuscitation MedlinePlus (2024) Apgar score. MedlinePlus Medical Encyclopedia. Available at: https://www.medlineplus.gov/ency/article/003402.htm American College of Obstetricians and Gynecologists (2015) Committee Opinion No. 644: The Apgar score. Obstetrics & Gynecology, 126(4), pp.e52–e55. DOI: 10.1097/AOG.0000000000001108. Available at: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2015/10/the-apgar-score LINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/Disclaimer: Please remember this video and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.
Breastfeeding may lower mothers' later-life risks of depression and anxiety for up to 10 years after pregnancy, according to new research from UCD. We discuss these findings with Fionnuala McAuliffe, Professor of Obstetrics and Gynecology at National Maternity Hospital Dublin.
Uterine rupture or dehiscence associated with TOLAC results in the most significant increase in the likelihood of additional maternal and neonatal morbidity. It should be noted that the terms “uterine rupture” and “uterine dehiscence” are not consistently distinguished from each other in the literature and often are used interchangeably. Furthermore, the reported incidence of uterine rupture varies in part because some studies have grouped true, catastrophic uterine rupture together with asymptomatic scar dehiscence. In January 2026, a new meta-analysis examines the relationship between oxytocin use with TOLAC and uterine rupture. In this episode, we will summarize the key findings in that study and review the data on the use of internal monitors during TOLAC. Do internal monitors (FSE, IUPC) offer a safer TOLAC compared with external monitors? Listen in for details.1. Nicolì, Pierpaolo et al.Oxytocin dosing during trial of labor after cesarean to minimize the risk of uterine rupture: a systematic review and meta-analysisAmerican Journal of Obstetrics & Gynecology MFM, Volume 8, Issue 1, 1018462. Practice Bulletin No. 184: Vaginal Birth After Cesarean Delivery. Obstetrics & Gynecology 130(5):p e217-e233, November 2017. | DOI: 10.1097/AOG.00000000000023983. ACOG Clinical Practice Guideline No. 10:Intrapartum Fetal Heart Rate Monitoring: Interpretation and Management. Obstetrics & Gynecology 146(4):p 583-599, October 2025. | DOI: 10.1097/AOG.00000000000060494. Bruno AM, Allshouse AA, Metz TD. Maximum Oxytocin Dose and Uterine Rupture During Trial of Labor After Cesarean. Obstet Gynecol. 2025 Dec 1;146(6):843-850. doi: 10.1097/AOG.0000000000006106. Epub 2025 Oct 30. PMID: 41325062.
In this episode, Dr. Blythe Bynum joins the show to discuss her new article titled Navigating Choices: Pregnancy Options Counseling Experiences in Individuals With Opioid Use Disorder, featured in the November/December issue of the Journal of Addiction Medicine. Dr. Blythe Bynum is an assistant professor in the Department of Obstetrics and Gynecology at Thomas Jefferson University in Philadelphia, Pennsylvania. She is a board certified OBGYN with fellowship training in Complex Family Planning. Article Link: Navigating Choices: Pregnancy Options Counseling Experiences in Individuals With Opioid Use Disorder
In this episode of the Critical Care Obstetrics podcast, Dr. Stephanie Martin and Suzanne Baird discuss the sensitive and critical topic of maternal mortality. They share a case study of a young mother with chronic hypertension, exploring the clinical challenges and management decisions that led to her tragic outcome. The conversation delves into the importance of communication, support for families, and the need for healthcare professionals to address maternal death openly. They also highlight the alarming statistics surrounding maternal mortality in the U.S. and share personal experiences that underscore the emotional toll on healthcare providers. The episode aims to foster a deeper understanding of maternal health issues and the importance of compassionate care in the face of loss.The experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...
In 2002, the National Institute of Child Health and Human Development (NICHD) proposed the 3-Tier fetal heart rate (FHR) classification system that was subsequently adopted by many organizations, categorizing tracings into three groups: Category I (normal), Category II (indeterminate), and Category III (abnormal). Recently, our podcast team received an interesting question form one of our podcast family members: “If there is a change in the fetal heart rate tracing intrapartum, but it is still in the normal range (like 120 going to 150)- and variability is normal, is that an abnormality? And what is meant by a ‘ZigZag' FHT pattern (different than marked variability)?”. That is a fantastically complex question…and we will explain the answer in this episode.1. Zullo F, Di Mascio D, Raghuraman N, Wagner S, Brunelli R, Giancotti A, Mendez-Figueroa H, Cahill AG, Gupta M, Berghella V, Blackwell SC, Chauhan SP. Three-tiered fetal heart rate interpretation system and adverse neonatal and maternal outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2023 Oct;229(4):377-387. doi: 10.1016/j.ajog.2023.04.008. Epub 2023 Apr 11. PMID: 37044237.2. Ghi T, Di Pasquo E, Dall'Asta A, et al. Intrapartum Fetal Heart Rate Between 150 and 160 BPM at or After 40 Weeks and Labor Outcome.Acta Obstetricia Et Gynecologica Scandinavica. 2021;100(3):548-554. doi:10.1111/aogs.14024.3. The 3 Tier System: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://ncc-efm.org/filz/NICHD_Reference_from_CCPR.pdf4. Jia YJ, Ghi T, Pereira S, Gracia Perez-Bonfils A, Chandraharan E. Pathophysiological Interpretation of Fetal Heart Rate Tracings in Clinical Practice. American Journal of Obstetrics and Gynecology. 2023;228(6):622-644. doi:10.1016/j.ajog.2022.05.0235. Ghi T, Di Pasquo E, Dall'Asta A, et al. Intrapartum Fetal Heart Rate Between 150 and 160 BPM at or After 40 Weeks and Labor Outcome. Acta Obstetricia Et Gynecologica Scandinavica. 2021;100(3):548-554. doi:10.1111/aogs.14024.6. Yang M, Stout MJ, López JD, Colvin R, Macones GA, Cahill AG. Association of Fetal Heart Rate Baseline Change and Neonatal Outcomes. Am J Perinatol. 2017 Jul;34(9):879-886. doi: 10.1055/s-0037-1600911. Epub 2017 Mar 16. PMID: 28301895.
Podcast Family, in our immediate past episode we tackled the discrepancy that is often found between a clinical diagnosis of intra-amniotic infection/chorioamnionitis and histological chorioamnionitis. From that episode, we received a fantastic question from one of our podcast family members: Can a patient have IAI without fever? That question is really deep and highlights a gap in the current diagnostic scheme/ criteria from the ACOG. Listen in for details!1. ACOG CO 7122. Sukumaran S, Pereira V, Mallur S, Chandraharan E. Cardiotocograph (CTG) Changes and Maternal and Neonatal Outcomes in Chorioamnionitis and/or Funisitis Confirmed on Histopathology. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2021. C3. Romero R, Chaemsaithong P, Korzeniewski SJ, et al. Clinical Chorioamnionitis at Term III: How Well Do Clinical Criteria Perform in the Identification of Proven Intra-Amniotic Infection? Journal of Perinatal Medicine. 2015.
In this episode of the Critical Care Obstetrics podcast, Dr. Stephanie Martin and Julie Arafey discuss a complex case involving a pregnant patient who experiences respiratory compromise leading to cardiac arrest. They explore the challenges in assessment, admission, and management of high-risk obstetric patients, emphasizing the importance of communication, monitoring, and emergency protocols. The conversation highlights the need for preparedness in handling obstetric emergencies, including the critical timing of resuscitative cesareans, and the necessity of training healthcare teams to respond effectively in such situations.The experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...
Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391.
Major health organizations, including the CDC and ACOG, recommend universal Hepatitis C Virus (HCV) screening for all pregnant women during each pregnancy and at time of delivery. Ideally, pregnant women should be screened for hepatitis C virus infection at the first prenatal visit of each pregnancy. If the antibody screen result is positive, hepatitis C virus RNA polymerase chain reaction testing is done to confirm the diagnosis. The risk of perinatal transmission of HCV is up to 9%, with at least one-third of transmissions occurring antenatally. While antiviral therapy is recommended for Hepatitis B in pregnancy with a viral load greater than 200,000 international units/mL to decrease the risk of vertical transmission, the same is not the case for Hep C. According to the ACOG CPG #6 from September 2023, there are no standard treatment protocols for Hep C in pregnancy but a new publication from the PINK journal (7 Dec 2025) is calling for a change. That new publication is, “Hepatitis C Treatment During Pregnancy: Time for a Practice Change”. Listen in for details. 1. ACOG CPG #6; Sept 20262. Bhattacharya D, Aronsohn A, Price J, Lo Re V. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2023;:ciad319. doi:10.1093/cid/ciad319.3. Chappell CA, Kiser JJ, Brooks KM, et al. Sofosbuvir/¬Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2025;80(4):744-751. doi:10.1093/cid/ciae595.4. Reau N, Munoz SJ, Schiano T. Liver Disease During Pregnancy. The American Journal of Gastroenterology. 2022;117(10S):44-52. doi:10.14309/ajg.0000000000001960.5. Dutra, Karley et al. Hepatitis C Treatment During Pregnancy: Time for a Practice Change. American Journal of Obstetrics & Gynecology MFM, Volume 0, Issue 0, 1018656. Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in Pregnancy-Updated Guidelines: Replaces Consult Number 43, November 2017. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Dotters-Katz SK, Kuller JA, Hughes BL. American Journal of Obstetrics and Gynecology. 2021;225(3):B8-B18. doi:10.1016/j.ajog.2021.06.008
In this episode of the Critical Care Obstetrics podcast, Julie Arafeh discusses the significance of interprofessional training in simulation sessions for healthcare teams, particularly in obstetrics. She emphasizes the necessity of including all team members in training to enhance collaboration and patient care. The conversation covers barriers to participation, incentives for physicians, the importance of confidentiality, and strategies for engaging multiple departments in simulation training. Julie provides practical tips for simulation instructors and encourages physicians to voice their needs to improve their training experience.TakeawaysSimulation based training is practice.You need to practice with the full team to get the complete benefit.If the nurses don't have access, the simulation is very nurse-centric.Identify what is problematic for people about the topic.Let people know what you're going to work on in simulation.Time is money for physicians, so scheduling is crucial.Physicians may hesitate to attend simulation due to fear of looking bad.Confidentiality in simulation allows for mistakes without blame.Interprofessional simulation enhances teamwork and patient outcomes.Engaging multiple departments in simulation is essential for comprehensive training.Chapters00:00 The Importance of Interprofessional Training04:41 Identifying Barriers to Participation10:32 Incentives for Physician Participation14:10 Overcoming Reluctance and Building Confidence19:44 Ensuring Confidentiality in Simulation25:35 Collaborative Interdepartmental SimulationsThe experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...
Today, we’re bringing you the best from the KUOW Newsroom… The small town of Mineral, Washington doesn’t have a lot of residents, or a lot of jobs - but they’re still taking care of each other. Six rural hospitals in Oregon and Washington have closed their obstetrics units since 2020, including one in northern Oregon earlier this year. And some colleges, including the University of Washington, have eliminated questions that reference diversity from their admissions applications in response to statements from the federal government. We can only make Seattle Now because listeners support us. Tap here to make a gift and keep Seattle Now in your feed. Got questions about local news or story ideas to share? We want to hear from you! Email us at seattlenow@kuow.org, leave us a voicemail at (206) 616-6746 or leave us feedback online.See omnystudio.com/listener for privacy information.
In the original Løvset maneuver (described for breech presentations), the fetus is rotated in one direction to facilitate arm delivery. For shoulder dystocia, the reverse Løvset applies rotation in the opposite direction—specifically rotating the posterior shoulder toward a "belly down" position through up to 180 degrees of rotation. These maneuvers were first described by Norwegian obstetrician Jørgen Løvset in the 1940s. Now, in the current November 2025 AJOG, this maneuver is back in the spotlight. In this episode, we will review the reverse Løvset maneuver for shoulder dystocia and review its effectiveness. Which maneuver is more likely to result in fetal brachial plexus injury? Listen in for details. 1. A critical evaluation of the external and internal maneuvers for resolution of shoulder dystocia, March 2024; AJOG. https://www.ajog.org/article/S0002-9378(23)00022-4/fulltext2. Grindheim, Sindre et al.Reverse Løvset maneuver for shoulder dystocia, American Journal of Obstetrics & Gynecology, Volume 233, Issue 5, 505.e1 - 505.e43. Leung TY, Stuart O, Suen SS, Sahota DS, Lau TK, Lao TT. Comparison of perinatal outcomes of shoulder dystocia alleviated by different type and sequence of manoeuvres: a retrospective review. BJOG. 2011 Jul;118(8):985-90. doi: 10.1111/j.1471-0528.2011.02968.x. Epub 2011 Apr 12. PMID: 21481159.4. Grobman WA, Miller D, Burke C, Hornbogen A, Tam K, Costello R. Outcomes associated with introduction of a shoulder dystocia protocol. Am J Obstet Gynecol. 2011;205(6):513−517.STRONG COFFEE PROMO CODE:https://strongcoffeecompany.com/discount/CHAPANOSPINOBG
My guest is Dr. Thaïs Aliabadi, MD, board-certified OB/GYN, surgeon and leading expert in women's health. We discuss polycystic ovary syndrome (PCOS) and endometriosis, two very common yet frequently undiagnosed causes of female infertility. Dr. Aliabadi explains the symptoms, underlying causes and evidence-based treatments for both conditions, including supplement and lifestyle interventions. We also discuss breast cancer risk and screening, pregnancy, perimenopause and menopause, and the hormone tests that women should request. This conversation offers empowering, potentially life-changing information for women of all ages to take control of their hormone, reproductive and overall health. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman Lingo: https://hellolingo.com/huberman Our Place: https://fromourplace.com/huberman Joovv: https://joovv.com/huberman LMNT: https://drinklmnt.com/huberman Function: https://functionhealth.com/huberman Timestamps 00:00 Thaïs Aliabadi 02:56 Why Endometriosis & Polycystic Ovary Syndrome (PCOS) Go Undiagnosed 08:16 Infertility, Tool: Early Screening 10:54 Sponsors: Lingo & Our Place 14:07 Women's Health Education Gap 15:24 PCOS Overview: Symptoms, Diagnosis, AMH, Disordered Eating 21:28 Irregular Periods, Teenage PCOS Diagnosis 24:36 Diagnosis, Pelvic Ultrasound; PCOS Naming 27:49 Thinning Hair & Acne; 4 PCOS Phenotypes; Mood & Treatment 35:54 Underlying Pillars of PCOS; HPA Axis, Androgens, Menstruation & Ovulation 40:30 Insulin Resistance & PCOS, Visceral Fat & Inflammation 46:30 Sponsors: AGZ by AG1 & Joovv 49:10 PCOS, Chronic Inflammation, Genetics & Lifestyle; Mood 52:31 PCOS, Fertility, Freezing Eggs, Tool: Egg Count & AMH Range By Age 58:34 Women's Health Education, AI, Clinicians; Cataracts Analogy 1:01:20 Stress; PCOS Treatment, Birth Control, Insulin Resistance & Metformin 1:06:44 PCOS Risk Calculator, Supplements, Lifestyle Factors; GLP-1s 1:12:32 Berberine, Metformin; GLP-1s, Food Anxiety & Alcohol 1:19:13 PCOS Prescriptions & Fertility; PCOS Co-Occurrence with Endometriosis 1:21:56 Sponsor: LMNT 1:23:16 PCOS Treatment, Freezing Eggs, Egg Quality; Advocate For Your Health 1:32:02 PCOS Key Takeaways: Symptoms, Tests, Supplements & Lifestyle 1:36:03 Undiagnosed Endometriosis, Fertility 1:39:26 Endometriosis: Symptoms, Diagnosis, Painful Periods, Infertility 1:42:30 Male vs Female Health Issues, Undiagnosed Endometriosis 1:47:01 Inflammation, Ectopic Implants, Chronic Pelvic Pain; Adenomyosis 1:50:36 Egg Quality, Endometriosis, Tools: Egg Counts; Pelvic Ultrasound 1:54:29 Sponsor: Function 1:56:13 Pain & Health Testing, Tool: Endometriosis Symptoms, Screening & Tests 2:01:32 Treatment, Surgery, Different Types of Endometriosis 2:05:22 Endometriosis Causes, Inflammation; Incidence, PCOS 2:11:58 Obstetrics & Gynecology Separation, Surgery 2:16:00 Endometriosis Key Takeaways: Symptoms, Treatment & Diagnosis 2:17:04 Treatment, Estrogen & Progesterone, Birth Control, GnRH Antagonists 2:22:39 Endometriosis Stage & Pain, Endometriosis Types 2:23:49 Pregnancy; Postpartum Depression, Menopause; Frustration for Patients 2:29:55 Fibroids, Surgery, Uterine Septum, Tool: Pelvic Ultrasound 2:34:05 Tool: Assessing Your & Partner's Fertility; Autoimmune Conditions 2:37:51 Breast Cancer, Tool: Lifetime Risk Calculator & Breast Imaging; Mastectomy 2:49:47 Endometriosis Tests, Autoimmune Disease; Brain Fog & Menopause; Inositol 2:53:06 Undiagnosed Infertility; PMDD Treatment; Fasting & Low-Carbohydrate Diets 2:57:21 Hair Loss & Perimenopause; Egg Quality; Endometriosis & Menopause 3:00:40 Increase Progesterone; Diet, Hormone & Menopause; Prolong Fertility 3:04:54 Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices
© 2020-2026 Ivy Podcast Discovery LLC
